We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Blocking Ephrin-A5 Spurs Recovery from Stroke in Mouse Model

By LabMedica International staff writers
Posted on 15 Aug 2012
Neuroscience researchers have identified a novel molecule in the brain that retards recovery from stroke by blocking the formation of new connections between neurons.

Investigators at the University of California, Los Angeles (USA) were attracted by the indication of increased production of the growth inhibitor ephrin-A5 by brain cells after stroke in a mouse model.

Ephrin-A5 is a protein encoded by a member of the ephrin gene family that prevents axon bundling in co-cultures of cortical neurons with astrocytes, a model of late stage nervous system development and differentiation. More...


Results published in the July 25, 2012, online edition of the journal Proceedings of the National Academy of Sciences of the USA (PNAS) revealed that damage to the brain induced ephrin-A5 production in reactive astrocytes where it acted as an inhibitor of axonal sprouting and motor recovery. Blocking ephrin-A5 signaling using a unique tissue delivery system induced the formation of a new pattern of axonal projections in motor, premotor, and prefrontal circuits and mediated recovery after stroke in the mice through these new projections. Combined blockade of ephrin-A5 and forced use of the affected limb promoted new and surprisingly widespread axonal projections within the entire cortical hemisphere on the same side of the body as the stroke.

If duplicated in humans, drugs to block ephrin-A5 activity could pave the way for a more rapid recovery from stroke and may allow a synergy with existing treatments, such as physical therapy.

Related Links:
University of California, Los Angeles




Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Rheumatoid Factors (RF) Test
Rheumatoid Factors (RF)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.